Login

Hemcheck | CEO interview, Joen Averstad, CEO, Hemcheck 00:00:00

Share On Facebook Share On Twitter

Hemcheck | CEO interview, Joen Averstad, CEO, Hemcheck

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Zimbabwe's ZIDA: Aiming for World-Class Standards and Efficiency in Investment
00:10:00
Biocept's Liquid Biopsy Innovations: CEO Mike Nall Discusses 2019 Achievements and 2020 Outlook
00:10:00
Exploration Expansion: Murchison Minerals Targets VMS Deposits in Saskatchewan
00:10:00
Defiance Silver Corp Presentation: Overview of Assets in Mexico
00:10:00
Mary Powell, Sunrun CEO, joins 'Closing Bell Overtime' to discuss the impact of the Inflation Reduction Act on the solar industry.
00:10:00
Insights from Stephen Ambrosini of 20/20 Financial Advisers
00:10:00
Exploring the Impact of Digital Transformation on Commercial Real Estate Financing | Patrick Turner, Managing Director,  Veronis Suhler Stevenson Capital Partner.
00:10:00
Prioritizing Clients' Interests: A Fiduciary Approach to Financial Planning
00:10:00
Basil Karampelas discusses ClearVue Technologies Ltd.'s vision and progress in an interview with The Market Herald.
00:10:00
Brickability Group PLC Wins AIM 'Transaction of the Year Award | Alan Simpson - CEO of Brickability Gr
00:10:00
Embracing the Market's Ebb and Flow: A Financial Perspective
00:10:00
Navigating Market Volatility and Personal Well-being Amid Economic Uncertainty

© 2017 - Neuhu+